From Nasdaq: 2025-06-10 19:31:00

Tench Coxe, a director at $NVDA, sold 1,000,000 shares of the company for $142,804,600 on 06-09-2025, representing approximately 3.6% of their shares. Following this trade, Coxe now owns 26,671,360 shares of $NVDA stock. In the last 6 months, $NVDA insiders traded the stock 40 times, with 0 purchases and 40 sales.

Members of Congress have traded $NVDA stock 51 times in the past 6 months, with 27 purchases and 24 sales. Representative Robert Bresnahan made 5 purchases and 6 sales, while Representative Marjorie Taylor Greene made 7 purchases. To track congressional stock trading, visit Quiver Quantitative’s congressional trading dashboard.

Wall Street analysts have issued 13 buy ratings for $NVDA recently, with no sell ratings. Recent ratings include “Outperform” by Wedbush and “Buy” by Benchmark. Multiple analysts have set price targets for $NVDA, with a median target of $172.5. Morgan Stanley set a target of $170.0, while Piper Sandler set a target of $180.0.

Hedge funds have made significant moves with $NVDA stock, with 2,731 institutional investors adding shares to their portfolio and 2,306 decreasing their positions in the most recent quarter. Notable additions include Goldman Sachs Group Inc and Bank of America Corp, while entities like Capital International Investors and Proficio Capital Partners LLC removed shares. Visit Quiver Quantitative’s institutional holdings dashboard to track hedge funds’ stock portfolios.



Read more at Nasdaq: Insider Sale: Director at $NVDA Sells 1,000,000 Shares